Shenzhen Paradise Precision Medical Technology Co., Ltd. is an innovative biopharmaceutical supplier with original, accurate, safe and significant efficacy, and a high-tech enterprise dedicated to the research and development and clinical application of original biological drugs in the world
CL Investment Group is positioned as a high-tech investment and real estate investment as the engine, with science and technology medical care and Internet finance as the wings, linking international resources and serving human health and technological development. At present, it has branches in New York, San Francisco, Los Angeles, Beijing, Shanghai, Xiamen, Langfang and other places in China. Paradise Capital, a subsidiary of Paradise Investment Group, is based in Silicon Valley to carry out venture capital business, and has invested in a number of start-ups in the fields of smart hardware, real estate Internet, and e-commerce. Paradise Capital's partners include many well-known Silicon Valley investment institutions, such as 500 Startups, AngelPad, Plug and Play, etc.
Paradise Investment Group established the Paradise Innovation Academy. Located in Silicon Valley, the Paradise Innovation Institute has attracted many outstanding talents to become mentors, including many academicians of the American Academy of Sciences, CEOs of well-known listed companies in the United States, and professors from Harvard, Stanford and other famous universities. These mentors not only serve the incubation program of Paradise Innovation Academy, but also provide consulting services for the transformation, scientific and technological progress and development of small and medium-sized enterprises in China. Paradise Capital and Paradise Innovation Academy are committed to helping potential entrepreneurial teams connect with Chinese and American resources, and bring high-tech from the United States to China, serve the Chinese market, and generate greater market value.
Paradise Investment Group established Paradise International Medical Company (www.clmedcare.com) to connect U.S. medical institutions and personnel with China's needs, and provide a series of services such as medical treatment in the United States. Paradise Real Estate, a subsidiary of Paradise Investment Group, has invested in the development of a number of residential and commercial properties in Manhattan, New York, San Francisco, California, Los Angeles, Shanghai, and Langfang, Hebei.
Paradise Investment Group invested in and founded the "Doctor Tree" Internet application. Doctor Tree is an information platform focusing on providing professional patient management and services for Chinese doctors, and is an online platform for doctor-patient services with "post-diagnosis" and "doctor-patient relationship" as the core model. Since the first version was launched in September 2014, there have been more than 50,000 active doctors on the Doctor Tree, serving more than 5 million patients in total, making it a leading post-diagnosis doctor-patient service platform in China. At the same time, Doctor Tree has launched the "Yao Kuaihao" Internet drug information service platform, which combines the two to form a closed loop of doctor-patient services and drug services to better serve patients.
